Boehringer Ingelheim has acquired Texan biotech Abexxa Biologics Inc., further expanding its cancer...
Newsletter
Error at the newsletter cancelation
There is a mistake occured at the cancelation. Please try again.
Up to Date
Following the $39bn Alexion buy-out completed in July, AstraZeneca plc announced it will invest €307m in the...
Bayer AG has joined forces with young Danish biotech Gubra ApS in a research collaboration and license...
Share
